Purple Biotech (XTAE:PPBT) 3-Year EBITDA Growth Rate : -29.30% (As of Dec. 2024)

View and export this data going back to 1978. Start your Free Trial

What is Purple Biotech 3-Year EBITDA Growth Rate?

Purple Biotech's EBITDA per Share for the three months ended in Dec. 2024 was ₪-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was -29.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 10.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 38.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Purple Biotech was 61.20% per year. The lowest was -29.30% per year. And the median was 43.40% per year.

Competitive Comparison of Purple Biotech's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Purple Biotech's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Purple Biotech's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Purple Biotech's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Purple Biotech's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Purple Biotech 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Purple Biotech (XTAE:PPBT) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Purple Biotech 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Purple Biotech's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Purple Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Purple Biotech Ltd (XTAE:PPBT) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

PPBT:USA

Address

4 Oppenheimer Street, Science Park, Rehovot, ISR, 7670104

Website

https://www.purple-biotech.com

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.